Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized pilot study of subcutaneous methylnaltrexone to reduce rectal interventions in terminal patients with opioid-induced constipation
2010-020520-22Phase 4Active
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylnaltrexone in opioid-induced constipation (OIC) (2 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoints: Number of bowel movements and Timing of bowel movements. Started Jun 2010; status: active.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2010-020520-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020520-22.